Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2016
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3Ajit Chande, Emilia Cristiana Cuccurullo, Annachiara Rosa, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 2017
The PYHIN Protein p205 Regulates the Inflammasome by Controlling Asc ExpressionSreya Ghosh, Christina Wallerath, Sergio Covarrubias, et al.Virology|October 23, 2017
Dynamics of lentiviral infection in vivo in the absence of adaptive immune responsesElissa J Schwartz, Naveen K Vaidya, Karin S Dorman, et al.Journal of Virology|September 27, 2008
Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanismHal P Bogerd, Rebecca L Tallmadge, J Lindsay Oaks, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
CRISPRi Screen Identifies a Novel Growth Suppressor lncRNA, INSTAR, in Human MonocytesChristy Montano, Eric Malekos, Sergio Covarrubias, et al.Nature Reviews. Immunology|May 24, 2014
Post-transcriptional regulation of gene expression in innate immunitySusan Carpenter, Emiliano P Ricci, Blandine C Mercier, et al.Retrovirology|December 24, 2014
Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA bindingChijioke N Umunnakwe, Hyelee Loyd, Kinsey Cornick, et al.Antiviral Research|August 17, 2017
Identification and characterization of small molecule inhibitors of porcine reproductive and respiratory syndrome virusAlyssa B Evans, Pengfei Dong, Hyelee Loyd, et al.Journal of Virology|May 6, 2011
Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiencySandra D Taylor, Steven R Leib, Wuwei Wu, et al.The Journal of Biological Chemistry|March 22, 2008
Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activationClaire E McCoy, Susan Carpenter, Eva M Pålsson-McDermott, et al.Pageof 11